Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trial
Vasiliki Patsiou(Aristotle University of Thessaloniki), George Giannakoulas(AHEPA University Hospital), Αναστάσιος Κάρτας(Aristotle University of Thessaloniki), Dimitrios V. Moysidis(Aristotle University of Thessaloniki), Αndreas S. Papazoglou(Aristotle University of Thessaloniki), Apostolos Tzikas(AHEPA University Hospital), Αlexandra Bekiaridou(Aristotle University of Thessaloniki), Athanasios Samaras(Aristotle University of Thessaloniki), Amalia Baroutidou(Aristotle University of Thessaloniki), Antonios Ziakas(Aristotle University of Thessaloniki)
Cited by 10
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
|EP Europace|2019|323
COVID-19 in Adults With Congenital Heart Disease
|Journal of the American College of Cardiology|2021|76
Prognostic significance of diabetes mellitus in patients with atrial fibrillation
|Cardiovascular Diabetology|2021|48